Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jpba.2014.02.021PMID 24667567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches.

  2013cited by this paper
• Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues☆

  2013cited by this paper
• Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.

  2012cited by this paper
• Significance of Heparanase in Cancer and Inflammation

  2012cited by this paper
• Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.

  2012cited by this paper
• Simple fluorescence assay for quantification of OSCS in heparin

  2011cited by this paper
• Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed

  2011cited by this paper
• Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.

  2011cited by this paper
• Algal fucoidan: structural and size-dependent bioactivities and their perspectives

  2011cited by this paper
• M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis

  2011cited by this paper
• Important Determinants for Fucoidan Bioactivity: A Critical Review of Structure-Function Relations and Extraction Methods for Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds

  2011cited by this paper
• Therapies from Fucoidan; Multifunctional Marine Polymers

  2011cited by this paper
• Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates.

  2010cited by this paper
• Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.

  2010cited by this paper
• Further studies on the composition and structure of a fucoidan preparation from the brown alga Saccharina latissima.

  2010cited by this paper
• Unraveling the Specificity of Heparanase Utilizing Synthetic Substrates*

  2010cited by this paper
• Evaluation of seasonal variations of the structure and anti-inflammatory activity of sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae).

  2009cited by this paper
• PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions.

  2009cited by this paper
• Heparin, heparan sulfate and heparanase in inflammatory reactions

  2009cited by this paper
• Optimized and standardized isolation and structural characterization of anti-inflammatory sulfated polysaccharides from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae).

  2009cited by this paper
• Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

  2008cited by this paper
• Elastase Inhibition Assay with Peptide Substrates – An Example for the Limited Comparability of in vitro Results

  2008cited by this paper
• Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides – comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea

  2008cited by this paper
• Cancer and thrombosis: from molecular mechanisms to clinical presentations

  2007cited by this paper
• Non-Anticoagulant Heparins and Inhibition of Cancer

  2007cited by this paper
• P‐selectin‐ and heparanase‐dependent antimetastatic activity of non‐anticoagulant heparins

  2007cited by this paper
• A fluorescent polymeric heparin sensor.

  2007cited by this paper
• Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

  2007cited by this paper
• Heparanase: a target for drug discovery in cancer and inflammation

  2007cited by this paper
• High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.

  2007cited by this paper
• O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.

  2007cited by this paper
• Development of heparanase inhibitors for anti-cancer therapy.

  2006cited by this paper
• The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.

  2006cited by this paper
• Colorimetric heparinase assay for alternative anti-metastatic activity.

  2006cited by this paper
• A MULTI‐GENE MOLECULAR INVESTIGATION OF THE KELP (LAMINARIALES, PHAEOPHYCEAE) SUPPORTS SUBSTANTIAL TAXONOMIC RE‐ORGANIZATION 1

  2006cited by this paper
• Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting*

  2005cited by this paper
• Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor.

  2005cited by this paper
• The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.

  2004cited by this paper
• Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC.

  2002cited by this paper
• Partial synthetic glucan sulfates as potential new antithrombotics: a review.

  2001cited by this paper
• Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

  2000cited by this paper
• CRM646-A and -B, novel fungal metabolites that inhibit heparinase.

  2000cited by this paper
• Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.

  1999cited by this paper
• Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation.

  1998cited by this paper
• Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation.

  1995cited by this paper
• Action pattern of polysaccharide lyases on glycosaminoglycans.

  1994cited by this paper
• Inhibition of tumor metastasis by heparanase inhibiting species of heparin.

  1994cited by this paper
• Gas-Liquid Chromatography-Mass Spectrometry Analysis of Anticoagulant Active Curdlan Sulfates

  1994cited by this paper
• Suramin. A potent inhibitor of melanoma heparanase and invasion.

  1991cited by this paper
• Examination of the substrate specificity of heparin and heparan sulfate lyases.

  1990cited by this paper
• Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

  1987cited by this paper
• Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour‐cell‐derived heparanases

  1987cited by this paper

• Heparanase as a therapeutic target for mitigating cancer progression.

  2025cites this paper
• Chemical toolbox to interrogate Heparanase-1 activity.

  2024cites this paper
• Production, characteristics and applications of microbial heparinases.

  2022cites this paper
• Heparanase Inhibitors in Cancer Progression: Recent Advances.

  2020cites this paper
• Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.

  2020cites this paper
• Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds

  2019influential citation
• Degradation of Eight Sulfated Polysaccharides Extracted from Red and Brown Algae and Its Impact on Structure and Pharmacological Activities.

  2019cites this paper
• The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard

  2018cites this paper
• Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.

  2017cites this paper
• Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase

  2016cites this paper
• Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.

  2016cites this paper